USA

CVS to launch two new drive-through COVID-19 testing sites

CVS Health Corp said that it will launch two new drive-through COVID-19 testing sites in Georgia and Rhode Island on Monday using new, faster tests than had previously been available, with up to four more locations to follow.

The company said both drive-through testing sites will use testing equipment made by Abbott Laboratories that can deliver results within minutes. It expects to be able to perform around 1,000 tests per day at each site.

"We want to get some experience under our belt with these sites and understand exactly sort of what the volume looks like. And we'll also be improving the logistics associated with each of the sites over time," CVS Chief Medical Officer Troy Brennan said in an interview.

Brennan said the company expects to announce a third testing site in a different state on Tuesday and could launch up to three more sites afterward. 

RELATED: Take a look a the coronavirus vaccine trials in Seattle: 


13 PHOTOS

Coronavirus vaccine trial in Seattle

See Gallery

A pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren)

Jennifer Haller poses for a photo in the living room of her home, Monday, March 16, 2020, in Seattle. Earlier in the day, Haller was the first person to receive a shot of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the start of the first-stage safety study clinical trial of the vaccine at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren)

Pharmacist Michael Witte opens a package taken from a freezer that contains the potential vaccine for COVID-19, the disease caused by the new coronavirus, on the first day of a first-stage safety study clinical trial of the vaccine, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren)

Pharmacist Michael Witte, left, gives Rebecca Sirull, right, a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. Sirull is the third patient to receive the shot in the study. (AP Photo/Ted S. Warren)

Jennifer Haller is reflected in a mirror as she waits in an exam room before she was given a shot in the first-stage safety study clinical trial of a potential coronavirus vaccine, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. Haller was the first person to receive the shot in the study. (AP Photo/Ted S. Warren)

Pharmacist Michael Witte, left, gives Neal Browning, right, a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. Browning is the second patient to receive the shot in the study. (AP Photo/Ted S. Warren)

The first clinical trials to find a coronavirus vaccine have begun at a hospital in Seattle. A total of 45 men and women have volunteered to be injected. Unlike most vaccines, these COVID-19 vaccines have not been tested on mice, and will go directly to humans due to the urgent need for the drug. Lisa Guerrero spoke with Neal Browning, one of the men who is participating in the trial. He explained what he has to go through as part of this brave new experiment.

The first clinical trials to find a coronavirus vaccine have begun at a hospital in Seattle. A total of 45 men and women have volunteered to be injected. Unlike most vaccines, these COVID-19 vaccines have not been tested on mice, and will go directly to humans due to the urgent need for the drug. Lisa Guerrero spoke with Neal Browning, one of the men who is participating in the trial. He explained what he has to go through as part of this brave new experiment.

Pharmacist Michael Witte, left, gives Rebecca Sirull, right, a shot in the first-stage safety study clinical trial of a potential vaccine for the coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. Sirull is the third patient to receive the shot in the study. (AP Photo/Ted S. Warren)

Dr. Lisa Jackson, a senior investigator at the Kaiser Permanente Washington Health Research Institute, poses for a photo, Sunday, March 15, 2020, in Seattle. Jackson is leading the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, which was given to the first volunteer in the study by injection, Monday, March 16 in Seattle. (AP Photo/Ted S. Warren)

Dr. Lisa Jackson, a senior investigator at the Kaiser Permanente Washington Health Research Institute, works in her office with an image of COVID-19 taped to her door, Sunday, March 15, 2020, in Seattle. Jackson is leading the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, which was given to the first volunteer in the study by injection, Monday, March 16. (AP Photo/Ted S. Warren)

Rebecca Sirull, center, poses for a photo with her roommates, Anna Thomas, left, and Madeleine Busch, Monday, March 16, 2020, at the home they share in Seattle. Earlier in the day, Sirull was the third person to receive a shot of a potential vaccine for the COVID-19 coronavirus at the start of the first-stage safety study clinical trial of the vaccine at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren)

Rebecca Sirull works on her laptop, Monday, March 16, 2020, at her home in Seattle. Earlier in the day, Sirull, an editorial coordinator for the Institute for Health Metrics and Evaluation, was the third person to receive a shot of a potential vaccine for the COVID-19 coronavirus at the start of the first-stage safety study clinical trial of the vaccine at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren)

HIDE CAPTION

SHOW CAPTION

CVS was part of a group of U.S. retailers that pledged at a White House news conference on March 13 to open the testing sites in their parking lots. CVS has only opened one drive-through testing site, in the parking lot of a CVS Pharmacy in Shrewsbury, Massachusetts.

Brennan said CVS was basically "shutting down that other model" of a single lane drive-through in the parking lot of one of its stores. A CVS spokeswoman said the Shrewsbury site is still operational, but the company is evaluating how and when to transition to this new model in Massachusetts.

The new testing sites will not be located in CVS parking lots. Instead, one will be located at Georgia Tech university and the other will be in the parking lot of a casino in Rhode Island.

CVS will supply personnel from its MinuteClinic unit to oversee the testing. The states will provide security and protective equipment.

The testing is currently available at no cost to patients, CVS said.

"Right now, the federal government's paying for these tests and will do so for a specific duration of time," Brennan said. "Then we'll develop the capability to bill insurance."

Patients will need to pre-register in advance online at CVS.com in order to schedule a same-day time slot for testing, the company said. Testing at the sites is for eligible individuals who meet criteria established by the Centers for Disease Control and Prevention (CDC), in addition to state residency and age guidelines. (Reporting by Michael Erman Editing by Nick Zieminski)

Football news:

Luis Garcia: Messi shows something new every year. I can easily imagine that he will play until 2025
Klopp on Henderson's injury: I don't know for sure yet, something's wrong with my knee. All we know is that it's not a small thing
Pavlyuchenko is seventh in the ranking of Tottenham's best forwards in the 21st century. Kane is the first (Squawka)
Manchester City made 93.7% of accurate passes in the match against Newcastle. This is an APL record
Ole Gunnar Solskjaer: 16 games unbeaten give confidence, but it is not something that Manchester United should aspire to
Havertz wants to go to Chelsea, he likes the project. Werner persuades him to go
Real Madrid has received almost 250 million euros from sales of Academy students over the past 4 years